Clinical trial
A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to…
NCT00192634 · Kirby Institute, Other · Completed
Key facts
| NCT number | NCT00192634 |
|---|---|
| Title | A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study |
| Official title | A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study. |
| Lead sponsor | Kirby Institute, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Emtricitabine 200mg - Tenofovir 300mg, Abacavir 600mg - Lamivudine 300mg |
| Enrollment | 357 |
| Start date | Dec 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | May 25, 2011 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: